Tumor marker elevations in chronic kidney disease: a retrospective study
PeerJ · 2025
DOI: 10.7717/peerj.19240 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Liuxia You und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2021 Fujian Province Young and Middle-aged Teachers’ Educational Research Project.
Abstract (Originalsprache)
Aim
To investigate the changes in tumor markers such as carbohydrate antigen 125 (CA125), carbohydrate antigen 153 (CA15-3), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 72-4 (CA72-4), pro-gastrin-releasing peptide (proGRP), and human epididymis protein 4 (HE4) in patients with chronic kidney disease (CKD) as compared to healthy individuals, and to analyze the potential indicators that can be utilized for monitoring early renal dysfunction, was the aim of this study.
Methods
This retrospective study involved 522 participants from our hospital, including 172 patients with CKD and 350 controls. CKD patients were divided into CKD1, CKD2, CKD3, CKD4, and CKD5 stages according to the estimated glomerular filtration rate (eGFR). Plasma creatinine and general clinical data were collected upon admission.
Results
The level of tumor biomarkers, including carcinoembryonic antigen (CEA), CA125, CA15-3, CA19-9, NSE, proGRP, and HE4, were elevated in patients with CKD ( p < 0.05). There were differences in CEA, CA125, CA19-9, NSE, proGRP, and HE4 between the control and CKD groups. The subgroup study showed that CEA, CA15-3, CA19-9, NSE, proGRP, and HE4 were elevated in patients with CKD having normal serum creatinine compared with those in the control group ( p < 0.05). ProGRP and HE4 have high predictive values for early renal insufficiency with area under the curve of 0.736 and 0.931, respectively ( p < 0.05). Furthermore, HE4 and proGRP were positively correlated with the stages of CKD, with correlation coefficients of 0.623 and 0.712, respectively.
Conclusions
Patients with CKD have higher tumor markers, some of which are helpful for the early diagnosis of renal impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
- Department of Emergency and Critical Care Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School of Nanjing Medical University, Suzhou, Jiangsu, China.
- Department of Internal Medicine, Guli People's Hospital, Suzhou, Jiangsu, China.
- Department of General Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Förderung
- 2021 Fujian Province Young and Middle-aged Teachers’ Educational Research Project
Zitieren
APA
You, L., Xu, Z., Liu, Q., Jin, G., & Wang, C. (2025). Tumor marker elevations in chronic kidney disease: a retrospective study. PeerJ. https://doi.org/10.7717/peerj.19240
Vancouver
You L, Xu Z, Liu Q, Jin G, Wang C. Tumor marker elevations in chronic kidney disease: a retrospective study. PeerJ. 2025. doi:10.7717/peerj.19240
BibTeX
@article{You2025,
author = {You, Liuxia and Xu, Zhongying and Liu, Qiaoling and Jin, Guoming and Wang, Changting},
title = {Tumor marker elevations in chronic kidney disease: a retrospective study},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19240}
}
EUVIMED